136 related articles for article (PubMed ID: 17472508)
1. Quality of life in patients with brain metastases treated with a palliative course of whole-brain radiotherapy.
Doyle M; Bradley NM; Li K; Sinclair E; Lam K; Chan G; Chow E; Barnes EA; Danjoux C; Tsao MN
J Palliat Med; 2007 Apr; 10(2):367-74. PubMed ID: 17472508
[TBL] [Abstract][Full Text] [Related]
2. Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases.
Chow E; Davis L; Holden L; Tsao M; Danjoux C
J Pain Symptom Manage; 2005 Jul; 30(1):18-23. PubMed ID: 16043003
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and symptoms control in brain metastasis after palliative whole brain radiotherapy using two different protocols.
Akhtar MS; Kousar F; Fatmi S; Jabeen K; Akhtar K
J Coll Physicians Surg Pak; 2012 May; 22(5):311-6. PubMed ID: 22538037
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of the palliative effect of whole-brain radiotherapy in patients with brain metastases and poor performance status.
Komosinska K; Kepka L; Niwinska A; Pietrzak L; Wierzchowski M; Tyc-Szczepaniak D; Kaczmarczyk A; Bujko K
Acta Oncol; 2010 Apr; 49(3):382-8. PubMed ID: 20397770
[TBL] [Abstract][Full Text] [Related]
5. Physician expectations of treatment outcomes for patients with brain metastases referred for whole brain radiotherapy.
Barnes EA; Chow E; Tsao MN; Bradley NM; Doyle M; Li K; Lam K; Danjoux C
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):187-92. PubMed ID: 19386437
[TBL] [Abstract][Full Text] [Related]
6. Proxy assessment of patients before and after radiotherapy for brain metastases. Results of a prospective study using the DEGRO brain module.
Steinmann D; Vordermark D; Geinitz H; Aschoff R; Bayerl A; Gerstein J; Hipp M; van Oorschot B; Wypior HJ; Schäfer C
Strahlenther Onkol; 2013 Jan; 189(1):47-53. PubMed ID: 23161120
[TBL] [Abstract][Full Text] [Related]
7. Assessing agreement between terminally ill cancer patients' reports of their quality of life and family caregiver and palliative care physician proxy ratings.
Jones JM; McPherson CJ; Zimmermann C; Rodin G; Le LW; Cohen SR
J Pain Symptom Manage; 2011 Sep; 42(3):354-65. PubMed ID: 21454041
[TBL] [Abstract][Full Text] [Related]
8. Substituting proxy ratings for patient ratings in cancer clinical trials: an analysis based on a Southwest Oncology Group trial in patients with brain metastases.
Moinpour CM; Lyons B; Schmidt SP; Chansky K; Patchell RA
Qual Life Res; 2000 Mar; 9(2):219-31. PubMed ID: 10983485
[TBL] [Abstract][Full Text] [Related]
9. Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity.
Agar M; Koh ES; Gibbs E; Barnes EH; Hovey E; Livingstone A; Sawkins K; Chye R; Lovell MR; Clark K; Vardy J; King M;
Support Care Cancer; 2016 Mar; 24(3):1209-18. PubMed ID: 26294320
[TBL] [Abstract][Full Text] [Related]
10. The use of significant others as proxy raters of the quality of life of patients with brain cancer.
Sneeuw KC; Aaronson NK; Osoba D; Muller MJ; Hsu MA; Yung WK; Brada M; Newlands ES
Med Care; 1997 May; 35(5):490-506. PubMed ID: 9140337
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the effect of palliative radiotherapy for cancer patients with intracranial metastases using EORTC-QOL-C30 questionnaire.
Yaneva MP; Semerdjieva MA
Folia Med (Plovdiv); 2006; 48(2):23-9. PubMed ID: 17408073
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for symptomatic bone metastases: a phase II study.
Hird A; Zhang L; Holt T; Fairchild A; DeAngelis C; Loblaw A; Wong R; Barnes E; Tsao M; Danjoux C; Chow E
Clin Oncol (R Coll Radiol); 2009 May; 21(4):329-35. PubMed ID: 19232483
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: a prospective study.
Habets EJ; Dirven L; Wiggenraad RG; Verbeek-de Kanter A; Lycklama À Nijeholt GJ; Zwinkels H; Klein M; Taphoorn MJ
Neuro Oncol; 2016 Mar; 18(3):435-44. PubMed ID: 26385615
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
Denham JW; Wilcox C; Joseph D; Spry NA; Lamb DS; Tai KH; Matthews J; Atkinson C; Turner S; Christie D; Gogna NK; Kenny L; Duchesne G; Delahunt B; McElduff P
Lancet Oncol; 2012 Dec; 13(12):1260-70. PubMed ID: 23151431
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018.
Regine WF; Schmitt FA; Scott CB; Dearth C; Patchell RA; Nichols RC; Gore EM; Franklin RL; Suh JH; Mehta MP
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1346-52. PubMed ID: 15050309
[TBL] [Abstract][Full Text] [Related]
17. FACT-Br for assessment of quality of life in patients receiving treatment for brain metastases: a literature review.
Lien K; Zeng L; Nguyen J; Cramarossa G; Cella D; Chang E; Caissie A; Holden L; Culleton S; Sahgal A; Chow E
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):701-8. PubMed ID: 22098286
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
Corn BW; Moughan J; Knisely JP; Fox SW; Chakravarti A; Yung WK; Curran WJ; Robins HI; Brachman DG; Henderson RH; Mehta MP; Movsas B
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):71-8. PubMed ID: 18164829
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases.
Steinmann D; Paelecke-Habermann Y; Geinitz H; Aschoff R; Bayerl A; Bölling T; Bosch E; Bruns F; Eichenseder-Seiss U; Gerstein J; Gharbi N; Hagg J; Hipp M; Kleff I; Müller A; Schäfer C; Schleicher U; Sehlen S; Theodorou M; Wypior HJ; Zehentmayr F; van Oorschot B; Vordermark D
BMC Cancer; 2012 Jul; 12():283. PubMed ID: 22780988
[TBL] [Abstract][Full Text] [Related]
20. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
Mehta MP; Tsao MN; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):37-46. PubMed ID: 16111570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
